160450-12-4 Usage
Uses
Used in Pharmaceutical Synthesis:
N-BOC-3-AMINO-4-CHLOROBENZOIC ACID is used as a key building block for the synthesis of various pharmaceuticals. Its presence in the molecular structure allows for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Production:
In the agrochemical industry, N-BOC-3-AMINO-4-CHLOROBENZOIC ACID is utilized as a precursor in the production of various agrochemicals, contributing to the development of effective crop protection agents.
Used in Organic Chemistry Reactions:
N-BOC-3-AMINO-4-CHLOROBENZOIC ACID is employed as a reagent in organic chemistry, particularly for the formation of amide bonds. Its use facilitates the synthesis of complex organic molecules and contributes to the advancement of organic chemistry research.
It is important to handle N-BOC-3-AMINO-4-CHLOROBENZOIC ACID with proper safety precautions due to its potential harmful effects if ingested or inhaled.
Check Digit Verification of cas no
The CAS Registry Mumber 160450-12-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,4,5 and 0 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 160450-12:
(8*1)+(7*6)+(6*0)+(5*4)+(4*5)+(3*0)+(2*1)+(1*2)=94
94 % 10 = 4
So 160450-12-4 is a valid CAS Registry Number.
160450-12-4Relevant articles and documents
Design and synthesis of α-ketoamides as cathepsin s inhibitors with potential applications against tumor invasion and angiogenesis
Chen, Jo-Chun,Uang, Biing-Jiun,Lyu, Ping-Chiang,Chang, Jang-Yang,Liu, Ko-Jiunn,Kuo, Ching-Chuan,Hsieh, Hsing-Pang,Wang, Hsin-Chieh,Cheng, Chao-Sheng,Chang, Yi-Hsun,Chang, Margaret Dah-Tsyr,Chang, Wun-Shaing Wayne,Lin, Chun-Cheng
scheme or table, p. 4545 - 4549 (2010/08/19)
A series of small molecules bearing an α-ketoamide warhead were synthesized and evaluated for their ability to inhibit cathepsin S, a key proteolytic enzyme upregulated in many cancers during tumor progression and metastasis. Most of the synthetic compounds were noncytotoxic, but several robustly inhibited cathepsin S (IC50 10 nM) and potently suppressed cell migration, invasion, and capillary tube formation. These results highlight the potential of α-ketoamide therapy for preventing or delaying cancer spread.
